Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)

2004

Heart , Volume 90 - Issue 9 p. 995- 998

Additional Metadata
Keywords	Stents/economics, Adult, Aged, Aged, 80 and over, Comparative Study, Coronary Restenosis/economics/prevention & control, Cost-Benefit Analysis, Drug Implants, Female, Humans, Immunosuppressive Agents/administration & dosage/economics, Length of Stay, Male, Middle Aged, Myocardial Infarction/etiology, Platelet Aggregation Inhibitors/therapeutic use, Sirolimus/administration & dosage/economics, Survival Analysis, Treatment Outcome
Persistent URL	hdl.handle.net/1765/8330
Journal	Heart
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Lemos Neto, P., & Serruys, P. (2004). Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart, 90(9), 995–998. Retrieved from http://hdl.handle.net/1765/8330

Publication